Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$584.39
-10.76-1.81%
al cierre: -
$588.04
3.650.62%
After hour: 7:53 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
GE Vernova Inc ha un obiettivo di prezzo di consenso pari a $612.28, stabilito in base alle ultime valutazioni degli analisti di 27. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Mizuho y JP Morgan il octubre 24, 2025, octubre 24, 2025 y octubre 23, 2025. Con un obiettivo di prezzo medio di $705.67 tra le Wells Fargo, Mizuho y JP Morgan, c'è un implicito 20.00% upside per GE Vernova Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Mizuho
JP Morgan
TD Cowen
Susquehanna
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para GE Vernova
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/24/2025 | 21.93% | Wells Fargo | $697 → $717 | Maintains | Overweight | |||
10/24/2025 | 12.24% | Mizuho | $677 → $660 | Maintains | Neutral | |||
10/23/2025 | 25.84% | JP Morgan | $715 → $740 | Maintains | Overweight | |||
10/23/2025 | 15.64% | TD Cowen | $685 → $680 | Maintains | Buy | |||
10/23/2025 | 27.54% | Susquehanna | $740 → $750 | Maintains | Positive | |||
10/23/2025 | 7.14% | RBC Capital | $605 → $630 | Maintains | Sector Perform | |||
10/23/2025 | 20.74% | BMO Capital | $690 → $710 | Maintains | Outperform | |||
10/23/2025 | 20.74% | Barclays | $706 → $710 | Maintains | Overweight | |||
10/23/2025 | 11.9% | Citigroup | $670 → $658 | Maintains | Neutral | |||
10/16/2025 | 17.34% | Morgan Stanley | $675 → $690 | Maintains | Overweight | |||
10/15/2025 | 28.9% | GLJ Research | $702 → $758 | Maintains | Buy | |||
10/15/2025 | 15.13% | Mizuho | $670 → $677 | Maintains | Neutral | |||
10/15/2025 | -19.22% | Rothschild & Co | → $475 | Downgrade | Neutral → Sell | |||
10/13/2025 | 25.84% | Susquehanna | $736 → $740 | Maintains | Positive | |||
09/15/2025 | 25.84% | Melius Research | → $740 | Upgrade | Hold → Buy | |||
09/12/2025 | 13.6% | Jefferies | $658 → $668 | Maintains | Hold | |||
09/05/2025 | -1.37% | HSBC | $570 → $580 | Maintains | Hold | |||
08/15/2025 | 11.9% | Jefferies | $620 → $658 | Maintains | Hold | |||
07/24/2025 | 13.94% | Citigroup | $544 → $670 | Maintains | Neutral | |||
07/24/2025 | 17.34% | BMO Capital | $590 → $690 | Maintains | Outperform | |||
07/24/2025 | 21.59% | JP Morgan | $620 → $715 | Maintains | Overweight | |||
07/24/2025 | 25.16% | Susquehanna | $662 → $736 | Maintains | Positive | |||
07/24/2025 | 18.53% | Wells Fargo | $474 → $697 | Maintains | Overweight | |||
07/24/2025 | 14.79% | Morgan Stanley | $511 → $675 | Maintains | Overweight | |||
07/24/2025 | 20.06% | Barclays | $580 → $706 | Maintains | Overweight | |||
07/24/2025 | 20.06% | Baird | $568 → $706 | Maintains | Outperform | |||
07/17/2025 | 5.44% | B of A Securities | $550 → $620 | Maintains | Buy | |||
07/16/2025 | 5.44% | JP Morgan | $460 → $620 | Maintains | Overweight | |||
07/14/2025 | -7.49% | Citigroup | $354 → $544 | Maintains | Neutral | |||
07/10/2025 | 7.14% | Seaport Global | → $630 | Initiates | → Buy | |||
07/09/2025 | -1.37% | Barclays | $550 → $580 | Maintains | Overweight | |||
07/08/2025 | 0.33% | BMO Capital | $522 → $590 | Maintains | Outperform | |||
07/07/2025 | 4.41% | UBS | → $614 | Initiates | → Buy | |||
06/24/2025 | -13.1% | Morgan Stanley | $422 → $511 | Maintains | Overweight | |||
06/23/2025 | 19.38% | GLJ Research | → $702 | Initiates | → Buy | |||
06/13/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
06/11/2025 | -6.47% | B of A Securities | $520 → $550 | Maintains | Buy | |||
06/10/2025 | -3.07% | Goldman Sachs | $500 → $570 | Maintains | Buy | |||
06/09/2025 | -6.47% | Barclays | $500 → $550 | Maintains | Overweight | |||
05/30/2025 | -11.23% | BMO Capital | $381 → $522 | Maintains | Outperform | |||
05/30/2025 | -14.97% | Barclays | $427 → $500 | Maintains | Overweight | |||
05/29/2025 | -12.08% | Jefferies | $427 → $517 | Downgrade | Buy → Hold | |||
05/16/2025 | -21.77% | JP Morgan | $430 → $460 | Maintains | Overweight | |||
05/14/2025 | -15.14% | Susquehanna | $399 → $499 | Maintains | Positive | |||
04/25/2025 | -27.39% | Jefferies | $418 → $427 | Maintains | Buy | |||
04/24/2025 | -35.38% | Guggenheim | $380 → $380 | Reiterates | Buy → Buy | |||
04/24/2025 | -28.24% | Morgan Stanley | $400 → $422 | Maintains | Overweight | |||
04/24/2025 | -32.15% | Susquehanna | $370 → $399 | Maintains | Positive | |||
04/24/2025 | -31.13% | Baird | $387 → $405 | Maintains | Outperform | |||
04/23/2025 | -26.88% | JP Morgan | $425 → $430 | Maintains | Overweight | |||
04/17/2025 | -28.92% | Jefferies | $413 → $418 | Maintains | Buy | |||
04/17/2025 | -35.38% | Guggenheim | $380 → $380 | Reiterates | Buy → Buy | |||
04/15/2025 | -34.19% | Baird | $448 → $387 | Maintains | Outperform | |||
04/14/2025 | -39.8% | Citigroup | $437 → $354 | Maintains | Neutral | |||
04/10/2025 | -27.73% | JP Morgan | $436 → $425 | Maintains | Overweight | |||
04/09/2025 | -35.21% | BMO Capital | $420 → $381 | Maintains | Outperform | |||
04/02/2025 | -37.08% | Susquehanna | → $370 | Initiates | → Positive | |||
03/27/2025 | -29.77% | Jefferies | $391 → $413 | Maintains | Buy | |||
03/18/2025 | -24.32% | RBC Capital | $453 → $445 | Maintains | Outperform | |||
03/05/2025 | -35.38% | Guggenheim | → $380 | Upgrade | Neutral → Buy | |||
03/03/2025 | -28.58% | BMO Capital | $471 → $420 | Maintains | Outperform | |||
03/03/2025 | -27.39% | Barclays | $487 → $427 | Maintains | Overweight | |||
02/19/2025 | — | CICC | — | Initiates | → Outperform | |||
02/13/2025 | -23.81% | Baird | → $448 | Initiates | → Outperform | |||
02/07/2025 | -27.73% | Johnson Rice | → $425 | Initiates | → Buy | |||
01/28/2025 | -22.96% | RBC Capital | $453 → $453 | Reiterates | Outperform → Outperform | |||
01/24/2025 | -35.38% | Guggenheim | $380 → $380 | Downgrade | Buy → Neutral | |||
01/24/2025 | -14.97% | Goldman Sachs | $446 → $500 | Maintains | Buy | |||
01/23/2025 | -20.07% | Truist Securities | $420 → $470 | Maintains | Buy | |||
01/23/2025 | -19.9% | BMO Capital | $420 → $471 | Maintains | Outperform | |||
01/23/2025 | -25.69% | Citigroup | $361 → $437 | Maintains | Neutral | |||
01/23/2025 | -17.18% | Barclays | $420 → $487 | Maintains | Overweight | |||
01/23/2025 | -25.86% | JP Morgan | $374 → $436 | Maintains | Overweight | |||
01/21/2025 | -28.58% | BMO Capital | $360 → $420 | Maintains | Outperform | |||
01/21/2025 | -11.57% | B of A Securities | $415 → $520 | Reiterates | Buy → Buy | |||
01/16/2025 | -24.15% | Goldman Sachs | $400 → $446 | Maintains | Buy | |||
01/16/2025 | -28.58% | Truist Securities | $400 → $420 | Maintains | Buy | |||
01/14/2025 | -29.43% | B of A Securities | $380 → $415 | Maintains | Buy | |||
01/14/2025 | -36.4% | JP Morgan | $367 → $374 | Maintains | Overweight | |||
12/13/2024 | -30.11% | Wells Fargo | $385 → $411 | Maintains | Overweight | |||
12/13/2024 | -33.51% | Jefferies | $348 → $391 | Maintains | Buy | |||
12/12/2024 | -31.98% | Goldman Sachs | $324 → $400 | Maintains | Buy | |||
12/11/2024 | -37.59% | JP Morgan | $356 → $367 | Maintains | Overweight | |||
12/11/2024 | -33.68% | Evercore ISI Group | $385 → $390 | Maintains | Outperform | |||
12/11/2024 | -35.38% | Guggenheim | $400 → $380 | Maintains | Buy | |||
12/11/2024 | -36.06% | RBC Capital | $376 → $376 | Reiterates | Outperform → Outperform | |||
12/10/2024 | -31.98% | Truist Securities | $325 → $400 | Maintains | Buy | |||
12/09/2024 | -38.61% | Citigroup | $292 → $361 | Maintains | Neutral | |||
12/05/2024 | -28.58% | Barclays | $320 → $420 | Maintains | Overweight | |||
12/05/2024 | -31.98% | Guggenheim | $300 → $400 | Maintains | Buy | |||
12/04/2024 | -31.47% | Wolfe Research | → $403 | Initiates | → Outperform | |||
12/03/2024 | -39.46% | JP Morgan | $330 → $356 | Maintains | Overweight | |||
11/25/2024 | -36.06% | RBC Capital | $285 → $376 | Maintains | Outperform | |||
11/21/2024 | -34.53% | Wells Fargo | → $385 | Initiates | → Overweight | |||
11/15/2024 | -37.59% | Morgan Stanley | $301 → $367 | Maintains | Overweight | |||
10/30/2024 | -42.86% | Daiwa Capital | $245 → $336 | Upgrade | Outperform → Buy | |||
10/24/2024 | -44.73% | Truist Securities | $300 → $325 | Maintains | Buy | |||
10/24/2024 | -48.81% | Morgan Stanley | $256 → $301 | Maintains | Overweight | |||
10/24/2024 | -51.53% | RBC Capital | $262 → $285 | Maintains | Outperform | |||
10/24/2024 | -45.07% | Evercore ISI Group | $300 → $323 | Maintains | Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de GE Vernova (GEV)?
El último precio objetivo de GE Vernova (NYSE:GEV) fue comunicado por Wells Fargo el octubre 24, 2025. La firma de analistas fijó un precio objetivo para $717.00 que espera GEV a rise dentro de 12 meses (un posible 21.93% upside). 96 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre GE Vernova (GEV)?
La última calificación de analistas para GE Vernova (NYSE:GEV) fue proporcionada por Wells Fargo, y GE Vernova mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de GE Vernova (GEV)?
La última revisión al alza de GE Vernova Inc se produjo en septiembre 15, 2025, cuando Melius Research elevó su precio objetivo a $740. Melius Research anteriormente tenía a hold para GE Vernova Inc.
¿Cuándo fue la última revisión a la baja de GE Vernova (GEV)?
La última revisión a la baja de GE Vernova Inc se produjo en octubre 15, 2025, cuando Rothschild & Co cambió su precio objetivo de N/A a $475 para GE Vernova Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para GE Vernova (GEV)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de GE Vernova, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de GE Vernova se registró el octubre 24, 2025, por lo que la próxima calificación estará disponible en torno al octubre 24, 2026.
¿Es correcta la calificación de los analistas sobre GE Vernova (GEV)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de GE Vernova (GEV) fue un mantuvo con un precio objetivo de $697.00 a $717.00. El precio actual al que cotiza GE Vernova (GEV) es de $588.04, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.